Phanes Therapeutics TO PRESENT AT BIOTECH SHOWCASE™ 2022 IN SAN FRANCISCO Company expects to file three INDs in 2022

SAN DIEGO: SAN DIEGO, Dec. 15, 2021 /PRNewswire/ — Phanes Therapeutics, Inc., an emerging biotech company focused on innovative drug discovery and development in immuno-oncology, today announced that it has scheduled a company presentation at Biotech Showcase™ 2022, to be held January 10–12, during the most important week in healthcare at the Hilton San Francisco Union Square. Dr. Ming Wang, CEO, will be presenting Phanes Therapeutics, Inc. at Biotech Showcase as follows:
Click here to view original post

ADVERTISEMENT — Advertise With Biotech Networks